logo
  +61 (0)2 9911 7200
our research your care Donate Now!

Medical Oncologists

 

Peter Hersey
Professor Peter Hersey MBBS, FRACP, D.Phil (Oxon)

Professor Peter Hersey graduated in medicine (University of Adelaide) and science (University of Oxford) where he completed a D.Phil in tumor immunology. He has worked closely with the Sydney and Newcastle Melanoma Units on immunological aspects of melanoma and has been the principal investigator for a number of clinical trials.

Dr Hersey is Professor of Melanoma Biology at The University of Sydney and Consultant Immunologist to the Melanoma Institute Australia. As a member of the International Melanoma Working Group and the Global Melanoma Task Force, he has contributed extensively to studies on sensitivity of melanoma cells to apoptosis induced by the immune system, chemotherapy and treatments which sensitize melanoma to therapy. He holds the view that overcoming resistance to cell death pathways in melanoma holds the key to advances in treatment of melanoma.

Dr Hersey is a joint holder of a NHMRC Program grant for studies on melanoma, is on the editorial board of a number of international journals and has contributed extensively to melanoma research with over 280 papers on original melanoma research.

2
Professor Richard Kefford AM, MBBS, PhD, FRACP

Professor Richard Kefford is Co-Director of Research at Melanoma Institute Australia. He is Professor of Medicine at The University of Sydney and Director of the Westmead Institute for Cancer Research, where much of the laboratory-based research of Melanoma Institute Australia is conducted. He is Professor of Medicine at Westmead Hospital and Consultant Medical Oncologist to Melanoma Institute Australia where he is involved in the conduct of a large number of clinical trials of new anti-melanoma drugs.

 

3
Professor Fran Boyle AM MBBS (QLD) FRACP PhD

Professor Boyle is a Medical Oncologist at North Sydney’s Mater Hospital, where she is Director of the Patricia Ritchie Centre for Cancer Care and Research, and Professor of Medical Oncology at the University of Sydney. Professor Boyle graduated from University of Queensland Medical School with Honours and a University Medal and undertook her initial physician training at the Mater in Brisbane before transferring to Royal North Shore Hospital in Sydney to complete her Medical Oncology training and a PhD in Pharmacology.

Professor Boyle's clinical practice focuses on breast cancer and melanoma, in association with Melanoma Institute Australia. Her current research interests include clinical trials of new cancer treatments, psychosocial and supportive care and communication. She was honoured with Membership of the Order of Australia in 2008 for services to cancer research, advocacy, policy development and professional education.

alt
Dr Georgina Long BSc PhD MBBS FRACP

Dr Georgina Long is a clinical researcher and Medical Oncologist at Melanoma Institute Australia and The University of Sydney, Australia. She was a Fulbright Postdoctoral Scholar at Scripps Research Institute.

Dr Long is an investigator on Phase I, II and III clinical trials in adjuvant and metastatic melanoma, and, with her colleagues at Westmead and Melanoma Institute Australia, spear-headed the investigation of BRAF inhibitor activity in the brain. She is a chief investigator on NHMRC funded research into the molecular biology of melanoma, with a particular focus on clinical and biomarker correlates of systemic therapy sensitivity and resistance. Since commencing at Melanoma Institute Australia in 2009, she has authored multiple publications in clinical and translational research in melanoma, is on advisory boards for drug development in melanoma, and is a regular invited speaker at international conferences.

6
Dr Catriona McNeil MBBS BSc(Med) PhD FRACP

Dr Catriona McNeil is an honours graduate of The University of Sydney. She undertook postgraduate medical training in Medical Oncology at Westmead Hospital, and later completed a PhD in molecular biology at the Garvan Institute of Medical Research. As a result of these studies she is a co-author of numerous scientific publications, and continues an active interest in Translational Cancer Research.

Dr McNeil is a Staff Specialist in Medical Oncology at the Sydney Cancer Centre, Royal Prince Alfred Hospital where she has a clinical interest in the care of patients with melanoma, lung cancer and breast cancer. She is actively involved in the development and conduct of clinical trials of new agents targeting these three cancer types.

 

Connect with us 
Copyright 2011, Melanoma Institute Australia. All Rights Reserved.